Intervention

Centricyte 1000

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions14

Lead sponsors shown3

Clinical trials

4 shown

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 InfectionNCT04326036 · 2020-03-25

Autologous Stem/Stromal Cells in Neurological Disorders and DiseaseNCT03297177 · 2020-01-01

Use of Stromal Vascular Fraction in Multiple SclerosisNCT03461419 · 2019-08-01

Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic ConditionsNCT02939859 · 2018-12-15

Common conditions

Autoimmune2 Multiple Sclerosis2 Altered Behavior in Alzheimer Disease1 COPD1 Coronavirus Infection1 Corticobasal Degeneration1 Dementia1 Demyelinating Autoimmune Diseases, CNS1 Demyelinating Sensorimotor Neuropathy1 Idiopathic Pulmonary Fibrosis1 Interstitial Lung Disease1 Parkinson1 Pulmonary Alveolar Proteinosis1 Viral Pneumonia1

Leading sponsors

Healeon Medical Inc2 Black Tie Medical, Inc.1 Regeneris Medical1

Trial status mix

UNKNOWN2

SUSPENDED1

WITHDRAWN1

Phase mix

NA2

EARLY_PHASE11

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.